ReviewRadiation protection dosimetry2021
X-RAY AND MOLECULAR IMAGING DURING PREGNANCY AND BREASTFEEDING-WHEN SHOULD WE BE WORRIED?
Review in Radiation protection dosimetry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Breastfeeding in metabolic and bariatric patients: a comprehensive guide for surgeons, patients, and the multidisciplinary team.Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery · 2025Review
- Prenatal environmental exposures and brain development: studies with baboons and other nonhuman primates.Advances in drug and alcohol research · 2025Review
- Clinical Characteristics of Postpartum Women With Hypoxia: A Retrospective Analysis of 92 Cases.International journal of general medicine · 2025Article
- Article
- Should Breastfeeding Be Interrupted after Radiological Imaging Examinations? Evidence and Clinical Applications.Children (Basel, Switzerland) · 2024Article
- Compare three deep learning-based artificial intelligence models for classification of calcified lumbar disc herniation: a multicenter diagnostic study.Frontiers in surgery · 2024Article
- Study protocol and rationale of "the UP project": evaluating the effectiveness of active breaks on health indicators in desk-based workers.Frontiers in public health · 2024Article
- Unmasking the Hidden Fetus: Introducing the Circled Delta Sign and Reversed Circled Delta Sign for Accurate Identification on Abdominal Radiography.The American journal of case reports · 2023Article
- Case series of catheter-based arrhythmia ablation in 13 pregnant women.Clinical cardiology · 2023Article
- The radiologist's role in a multidisciplinary approach to cancer in pregnancy.Abdominal radiology (New York) · 2023Review
- Idiopathic Spontaneous Occurrence of Heterotrophic Occurrence During Pregnancy.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2023Article
- Imaging of heart disease in women: review and case presentation.European journal of nuclear medicine and molecular imaging · 2022Review
- [Postoperative imaging of the musculoskeletal system : Clinical aspects].Radiologie (Heidelberg, Germany) · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Some of the ethically most sensitive issues in radiation protection arise at imaging of pregnant-and potentially pregnant-patients and of newborn. This article reviews the current literature and recommendations on imaging during pregnancy and breastfeeding. Risks related to alternative non-ionizing radiation methods are also considered. With few exceptions, exposure of the fetus through radiography, computed tomography (CT) and nuclear medicine imaging can be limited to safe levels, although studies such as abdominal-pelvic CT cannot avoid significant exposure to fetuses. Eight to 10 weeks post-conception, the fetus has a thyroid which starts to concentrate iodide having crossed the placenta barrier resulting in unacceptably high doses to the fetal thyroid after administration of 131I- and even 123I-iodide and other radiopharmaceuticals with a high content of free radioiodine. Many radiopharmaceuticals are excreted through breast milk. Breastfeeding interruption recommendations should be followed to keep the effective dose to the infant below 1 mSv.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.